Isoflavones for hypercholesterolaemia in adults

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 6, 2013, Pages

  Qin, Yu ^a   Niu, Kai ^a   Zeng, Yuan ^a   Liu, Peng ^a   Yi, Long ^a   Zhang, Ting ^a   Zhang, Qian Yong ^a   Zhu, Jun Dong ^a   Mi, Man Tian ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SEX HORMONE BINDING GLOBULIN; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

BLOATING; CAUSAL ATTRIBUTION; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONSTIPATION; COST BENEFIT ANALYSIS; DRUG EFFICACY; HOT FLUSH; HUMAN; HYPERCHOLESTEROLEMIA; META ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; TRIACYLGLYCEROL BLOOD LEVEL; ADULT; AGED; FEMALE; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; ISOFLAVONES; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOYBEAN PROTEINS;

EID: 84891702274     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009518.pub2     Document Type: Review

References (74)

1. Aubertin-Leheudre M, Lord C, Khalil A, Dionne IJ. Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study. Menopause 2007;14(4):624-9. [MEDLINE: 17290158]
2. Aubertin-Leheudre M, Lord C, Khalil A, Dionne IJ. Isoflavones and clinical cardiovascular risk factors in obese postmenopausal women: a randomized double-blind placebo-controlled trial. Journal of Womens Health 2008;17:1363-9.
3. Dewell A, Hollenbeck CB, Bruce B. The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2002;87(1):118-21. [MEDLINE: 11788633]
4. Gardner CD, Newell KA, Cherin R, Haskell WL. The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. American Journal of Clinical Nutrition 2001;73(4):728-35. [MEDLINE: 11273847]
5. Mackey R, Ekangaki A, Eden JA. The effects of soy protein in women and men with elevated plasma lipids. Biofactors 2000;12(1-4):251-7. [MEDLINE: 11216493]
6. Wang YS, Zhang GR, Liu YJ, Zhuo HX, Xia FL. Effects of isoflavones on blood lipid profiles in perimenopausal women. Zhong Hua Xian Dai Zhong Xi Yi Za Zhi 2005;3(19):1738-9.
7. Atkinson C, Oosthuizen W, Scollen S, Loktionov A, Day NE, Bingham SA. Modest protective effects of isoflavones from a red clover-derived dietary supplement on cardiovascular disease risk factors in perimenopausal women, and evidence of an interaction with ApoE genotype in 49-65 year-old women. Journal of Nutrition 2004;134(7):1759-64. [MEDLINE: 15226466]
8. Badeau R, Jauhiainen M, Metso J, Nikander E, Tikkanen MJ, Ylikorkala O, et al.Effect of isolated isoflavone supplementation on ABCA1-dependent cholesterol efflux potential in postmenopausal women. Menopause 2007;14(2):293-9. [MEDLINE: 17224860]
9. Blakesmith SJ, Lyons-Wall PM, George C, Joannou GE, Petocz P, Samman S. Effects of supplementation with purified red clover (Trifolium pratense) isoflavones on plasma lipids and insulin resistance in healthy premenopausal women. British Journal of Nutrition 2003;89(4):467-74. [MEDLINE: 12654164]
10. Cancellieri F, De Leo V, Genazzani AD, Nappi C, Parenti GL, Polatti F, et al.Efficacy on menopausal neurovegetative symptoms and some plasma lipids blood levels of an herbal product containing isoflavones and other plant extracts. Maturitas 2007;56(3):249-56. [MEDLINE: 17275225]
11. Chedraui P, San Miguel G, Hidalgo L, Morocho N, Ross S. Effect of Trifolium pratense-derived isoflavones on the lipid profile of postmenopausal women with increased body mass index. Gynecological Endocrinology 2008;24(11):620-4. [MEDLINE: 19031218]
12. Cheng G, Wilczek B, Warner M, Gustafsson JA, Landgren BM. Isoflavone treatment for acute menopausal symptoms. Menopause 2007;14:468-73. [MEDLINE: 17290160]
13. Cianci A, Cicero AF, Colacurci N, Matarazzo MG, De Leo V. Activity of isoflavones and berberine on vasomotor symptoms and lipid profile in menopausal women. Gynecological Endocrinology 2012;28:699-702. [MEDLINE: 22313171]
14. Colacurci N, Chiàntera A, Fornaro F, de Novellis V, Manzella D, Arciello A. Effects of soy isoflavones on endothelial function in healthy postmenopausal women. Menopause 2005;12(3):299-307. [MEDLINE: 15879919]
15. Dent SB, Peterson CT, Brace LD, Swain JH, Reddy MB, Hanson KB, et al.Soy protein intake by perimenopausal women does not affect circulating lipids and lipoproteins or coagulation and fibrinolytic factors. Journal of Nutrition 2001;131(9):2280-7. [MEDLINE: 11533267]
16. Fornaro F, Carotenuto V, Bisogni C, Trabucco E, Russo C, Manzella D, et al.Brachial reactivity in postmenopausal women: Impact of soy isoflavone administration. Italian Journal of Gynaecology and Obstetrics 2006;18:106-10. [EMBASE: 44822700]
17. Gallagher JC, Satpathy R, Rafferty K, Haynatzka V. The effect of soy protein isolate on bone metabolism. Menopause 2004;11(3):290-8. [MEDLINE: 15167308]
18. Garrido A, De la Maza MP, Hirsch S, Valladares L. Soy isoflavones affect platelet thromboxane A2 receptor density but not plasma lipids in menopausal women. Maturitas 2006;54(3):270-6. [MEDLINE: 16414215]
19. Gonzalez S, Jayagopal V, Kilpatrick ES, Chapman T, Atkin SL. Effects of isoflavone dietary supplementation on cardiovascular risk factors in type 2 diabetes. Diabetes Care 2007;30:1871-3. [EMBASE: 47036769; MEDLINE: 17468359]
20. Han KK, Soares JM Jr, Haidar MA, de Lima GR, Baracat EC. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstetrics and Gynecology 2002;99(3):389-94. [MEDLINE: 11864664]
21. Hidalgo LA, Chedraui PA, Morocho N, Ross S, San Miguel G. The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study. Gynecological Endocrinology 2005;21(5):257-64. [MEDLINE: 16373244]
22. Ho SC, Chen YM, Ho SS, Woo JL. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial. Menopause 2007;14(5):905-12. [MEDLINE: 17413839]
23. Jiang M, Xu YF, Miao ZL, Zhong XM, Zhang M, Liu N. Effects of isoflavones on blood lipid profiles in perimenopausal women. ZhongGuo Shi Yong Yi Yao 2008;3(17):49-50.
24. Lee M, Chae S, Cha Y, Park Y. Supplementation of Korean fermented soy paste doenjang reduces visceral fat in overweight subjects with mutant uncoupling protein-1 allele. Nutrition Research 2012;32:8-14. [MEDLINE: 22260858]
25. Liang SP, Zhang DP. Observation and analysis of the lipid-lowering effects of oat soy flour. ZhongGuo Wu Zhen Xue Za Zhi 2007;7(3):466.
26. Llaneza P, Gonzalez C, Fernandez-Iñarrea J, Alonso A, Diaz-Fernandez MJ, Arnott I, et al.Soy isoflavones, Mediterranean diet, and physical exercise in postmenopausal women with insulin resistance. Menopause 2010;17(2):372-8. [EMBASE: 2010168638; MEDLINE: 20216276]
27. Marini H, Bitto A, Altavilla D, Burnett BP, Polito F, Di Stefano V, et al.Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: a follow-up study. Nutrition Metabolism and Cardiovascular Diseases 2010;20(5):332-40. [MEDLINE: 19631515]
28. Nikander E, Tiitinen A, Laitinen K, Tikkanen M, Ylikorkala O. Effects of isolated isoflavonoids on lipids, lipoproteins, insulin sensitivity, and ghrelin in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2004;89(7):3567-72. [MEDLINE: 15240647]
29. Oliveira LP, de Jesus RP, Boulhosa RS, Mendes CM, Gnoatto MC, Lemaire DC, et al.Effect of soy protein supplementation in patients with chronic hepatitis C: a randomized clinical trial. World Journal of Gastroenterology 2012;18(18):2203-11. [MEDLINE: 22611313]
30. OzturkTurhan N, Iltemir Duvan C, Bolkan F, Onaran Y. Effect of isoflavone on plasma nitrite/nitrate, homocysteine, and lipid levels in Turkish women in the early postmenopausal period: a randomized controlled trial. Turkish Journal of Medical Sciences 2009;39:367-75. [EMBASE: 354824750]
31. Petri Nahas E, Nahás Neto J, De Luca L, Traiman P, Pontes A, Dalben I. Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy. Maturitas 2004;48(4):372-80. [MEDLINE: 15283929]
32. Rios DR, Rodrigues ET, Cardoso AP, Montes MB, Franceschini SA, Toloi MR. Lack of effects of isoflavones on the lipid profile of Brazilian postmenopausal women. Nutrition 2008;24(11-12):1153-8. [MEDLINE: 18842392]
33. Schult TM, Ensrud KE, Blackwell T, Ettinger B, Wallace R, Tice JA. Effect of isoflavones on lipids and bone turnover markers in menopausal women. Maturitas 2004;48(3):209-18. [MEDLINE: 15207886]
34. Swain JH, Alekel DL, Dent SB, Peterson CT, Ready MB. Iron indexes and total antioxidant status in response to soy protein intake in perimenopausal women. American Journal of Clinical Nutrition 2002;76:165-71. [EMBASE: 34686562]
35. Terzic MM, Dotlic J, Maricic S, Mihailovic T, Tosic-Race B. Influence of red clover-derived isoflavones on serum lipid profile in postmenopausal women. Journal of Obstetrics and Gynaecology Research 2009;35(6):1091-5. [MEDLINE: 20144173]
36. Törmälä RM, Nikander E, Tiitinen A, Väisänen-Tommiska M, Ylikorkala O, Mikkola TS. Serum cholesterol efflux potential in postmenopausal women treated with isolated isoflavones. Menopause 2006;13(1):96-101. [MEDLINE: 16607104]
37. Uesugi T, Toda T, Okuhira T, Chen JT. Evidence of estrogenic effect by the three-month-intervention of isoflavone on vaginal maturation and bone metabolism in early postmenopausal women. Endocrine Journal 2003;50:613-9. [MEDLINE: 14614218]
38. Villa P, Costantini B, Suriano R, Perri C, Macrì F, Ricciardi L, et al.The differential effect of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women: relationship with the metabolic status. Journal of Clinical Endocrinology and Metabolism 2009;94(2):552-8. [MEDLINE: 19017760]
39. Wong JM, Kendall CW, Marchie A, Liu Z, Vidgen E, Holmes C, et al.Equol status and blood lipid profile in hyperlipidemia after consumption of diets containing soy foods. American Journal of Clinical Nutrition 2012;95(3):564-71. [MEDLINE: 22301925]
40. Woo J, Lau E, Ho SC, Cheng F, Chan C, Chan AS, et al.Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause. Menopause 2003;10(4):352-61. [MEDLINE: 12851519]
41. Wu J, Oka J, Tabata I, Higuchi M, Toda T, Fuku N, et al.Effects of isoflavone and exercise on BMD and fat mass in postmenopausal Japanese women: a 1-year randomized placebo-controlled trial. Journal of Bone and Mineral Research 2006;21(5):780-9. [MEDLINE: 16734394]
42. Wu J, Oka J, Higuchi M, Tabata I, Toda T, Fujioka M, et al.Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial. Metabolism: Clinical and Experimental 2006;55(4):423-33. [MEDLINE: 16546471]
43. Xiao LZ, Jiang ZP, Xu X, Huang Z, Lai SY, Hu BH. Effects of isoflavones on blood lipid profiles and endothelial function in postmenopausal women. Lin Chung Xin Xue Guan Bing Za Zhi 2003;19(5):302-3.
44. Ye YB, Wang ZL, Zhuo SY, Lu W, Liao HF, Verbruggen M, et al.Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese women: a randomized placebo-controlled trial. Menopause 2012;19:791-8. [MEDLINE: 22278344]
45. Yildiz MF, Kumru S, Godekmerdan A, Kutlu S. Effects of raloxifene, hormone therapy, and soy isoflavone on serum high-sensitive C-reactive protein in postmenopausal women. International Journal of Gynaecology and Obstetrics 2005;90(2):128-33. [MEDLINE: 15970291]
46. Albertazzi P, Steel SA, Bottazzi M. Effect of pure genistein on bone markers and hot flushes. Climacteric 2005;8(4):371-9. [PUBMED: 16390772]
47. Badimon L, Storey RF, Vilahur G. Update on lipids, inflammation and atherothrombosis. Thrombosis and Haemostasis 2011;105 Suppl 1:S34-42. [PUBMED: 21479344]
48. Chun OK, Chung SJ, Song WO. Estimated dietary flavonoid intake and major food sources of U.S. adults. Journal of Nutrition 2007;137(5):1244-52. [PUBMED: 17449588]
49. Duncan AM, Merz-Demlow BE, Xu X, Phipps WR, Kurzer MS. Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiology, Biomarkers and Prevention 2000;9(6):581-6. [PUBMED: 10868692]
50. Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek, et al.National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet 2011;377(9765):578-86. [PUBMED: 21295847]
51. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al.Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. New England Journal of Medicine 2007;356(23):2388-98. [PUBMED: 17554120]
52. He J, Gu D, Reynolds K, Wu X, Muntner P, Zhao J, et al.Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation 2004;110(4):405-11. [PUBMED: 15238453]
53. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58.
54. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003;327(7414):557-60.
55. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
56. Jackson RL, Greiwe JS, Schwen RJ. Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist. Nutrition Reviews 2011;69(8):432-48. [PUBMED: 21790611]
57. Kang X, Zhang Q, Wang S, Huang X, Jin S. Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy. Canadian Medical Association Journal 2010;182(17):1857-62. [PUBMED: 20956506]
58. Keinan-Boker L, Peeters PH, Mulligan AA, Navarro C, Slimani N, Mattisson I, et al.Soy product consumption in 10 European countries: the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutrition 2002;5(6B):1217-26. [PUBMED: 12639228]
59. Kreijkamp-Kaspers S, Kok L, Bots ML, Grobbee DE, Lampe JW, Van der Schouw YT. Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women. American Journal of Clinical Nutrition 2005;81(1):189-95. [PUBMED: 15640479]
60. Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. American Journal of Epidemiology 2005;162(8):764-73. [PUBMED: 16150890]
61. Lau J, Ioannidis JPA, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ 2006;333(7568):597-600.
62. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al.The PRISMA statement for reporting systematic and meta-analyses of studies that evaluate interventions: explanation and elaboration. PLoS Medicine 1999;6(7):1-28. [DOI: 10.1371/journal.pmed.1000100]
63. Liu D, Zhen W, Yang Z, Carter JD, Si H, Reynolds KA. Genistein acutely stimulates insulin secretion in pancreatic beta-cells through a cAMP-dependent protein kinase pathway. Diabetes 2006;55(4):1043-50. [PUBMED: 16567527]
64. Liu B, Qin L, Liu A, Uchiyama S, Ueno T, Li X, et al.Prevalence of the equol-producer phenotype and its relationship with dietary isoflavone and serum lipids in healthy Chinese adults. Journal of Epidemiology 2010;20(5):377-84. [PUBMED: 20671375]
65. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. Journal of Nutrition 2002;132(12):3577-84. [PUBMED: 12468591]
66. Setchell KD, Clerici C. Equol: history, chemistry, and formation. Journal of Nutrition 2010;140(7):1355S-62S. [PUBMED: 20519412]
67. Shimazu T, Inoue M, Sasazuki S, Iwasaki M, Sawada N, Yamaji T, et al.Isoflavone intake and risk of lung cancer: a prospective cohort study in Japan. American Journal of Clinical Nutrition 2010;91(3):722-8. [PUBMED: 20071645]
68. Sterne JAC, Egger M, Davey Smith G. Investigating and dealing with publication and other biases. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic Reviews in Health Care; Meta-analysis in Context. London: BMJ Publishing Group, 2001:189-208.
69. Taku K, Umegaki K, Sato Y, Taki Y, Endoh K, Watanabe S. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. American Journal of Clinical Nutrition 2007;85(4):1148-56. [PUBMED: 17413118]
70. Taku K, Umegaki K, Ishimi Y, Watanabe S. Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: meta-analysis of randomized controlled trials. Therapeutics and Clinical Risk Management 2008;4(5):1097-103. [PUBMED: 19209289]
71. Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S, Di Renzo GC. Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Fertility and Sterility 2004;82(1):145-8. [PUBMED: 15237003]
72. Weggemans RM, Trautwein EA. Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. European Journal of Clinical Nutrition 2003;57(8):940-6. [DOI: :10.1038/sj.ejcn.1601628]
73. Zhan S, Ho SC. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. American Journal of Clinical Nutrition 2005;81(2):397-408. [PUBMED: 15699227]
74. Zhuo XG, Melby MK, Watanabe S. Soy isoflavone intake lowers serum LDL cholesterol: a meta-analysis of 8 randomized controlled trials in humans. Journal of Nutrition 2004;134(9):2395-400. [PUBMED: 15333734]